Literature DB >> 8680479

Endocrine and paracrine negative regulators of adipose differentiation.

G Serrero1, N Lepak.   

Abstract

Obesity which is characterized by an abnormal adipose tissue development is a first degree public health hazard in industrialized countries. One important aspect in the study of adipose tissue development is to investigate the hormonal control of proliferation and differentiation. Any qualitative or quantitative change in these hormones or their receptors can result in abnormalities in the process of proliferation and/or differentiation possibly leading to obesity. Therefore, it is important to identify these factors and investigate their mechanism of action. We have concentrated our efforts in the study of factors triggering differentiation (positive regulators) and also of factors inhibiting differentiation (negative regulators). The present paper provides evidence of the importance of EGF/TGF-alpha and of PGF2 alpha as differentiation inhibitors for adipocyte precursors in primary culture. Data presented here also demonstrate that TGF-alpha is expressed in adipose tissue and that its expression is specifically stimulated by PGF2 alpha, thus suggesting the existence of an amplification mechanism between two differentiation inhibitors within the adipose tissue. The importance of these two types of differentiation inhibitors in the regulation of adipose tissue development is discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8680479

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  8 in total

Review 1.  Emerging paradigms for understanding fatness and diabetes risk.

Authors:  Steven R Smith; Eric Ravussin
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

2.  Adipose tissue engineering with cells in engineered matrices.

Authors:  Lauren Flynn; Kimberly A Woodhouse
Journal:  Organogenesis       Date:  2008-10       Impact factor: 2.500

3.  Insulin but not IGF-I is required for the maintenance of the adipose phenotype in the adipogenic cell line 1246.

Authors:  G Serrero; N Lepak
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999 Nov-Dec       Impact factor: 2.416

4.  In vitro study of antiadipogenic profile of latanoprost, travoprost, bimatoprost, and tafluprost in human orbital preadiopocytes.

Authors:  Hee Young Choi; Ji Eun Lee; Ji Woong Lee; Hyun Jun Park; Ji Eun Lee; Jae Ho Jung
Journal:  J Ocul Pharmacol Ther       Date:  2011-11-22       Impact factor: 2.671

5.  Dietary fatty acids early in life affect lipid metabolism and adiposity in young rats.

Authors:  Ana Paula S Silva; Daniella E D Guimarães; Daniella M Mizurini; Ingrid C Maia; Susana Ortiz-Costa; Fátima L Sardinha; Maria G Tavares do Carmo
Journal:  Lipids       Date:  2006-06       Impact factor: 1.880

6.  Changes to upper eyelid orbital fat from use of topical bimatoprost, travoprost, and latanoprost.

Authors:  Juwan Park; Hyun Kyung Cho; Jung-Il Moon
Journal:  Jpn J Ophthalmol       Date:  2011-02-18       Impact factor: 2.447

Review 7.  Human Adipose Tissue Derivatives as a Potent Native Biomaterial for Tissue Regenerative Therapies.

Authors:  Siva Sankari Sharath; Janarthanan Ramu; Shantikumar Vasudevan Nair; Subramaniya Iyer; Ullas Mony; Jayakumar Rangasamy
Journal:  Tissue Eng Regen Med       Date:  2020-01-17       Impact factor: 4.169

8.  Topical prostaglandin analogue drugs inhibit adipocyte differentiation.

Authors:  Jae Woo Kim
Journal:  Korean J Ophthalmol       Date:  2014-05-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.